Ethical Considerations Regarding Psychedelics for Clinical Pain Research.
Journal of Pain Research 2024 Christopher L. Robinson, Matthew Slitzky, Michael E Schatman et al. 4 citations
Psychedelics, substances with a long history of cultural and medicinal use, are experiencing a resurgence in clinical research, particularly in psychiatry. Despite their classification as Schedule I drugs, recent studies suggest therapeutic potential, particularly in treating refractory depression. With chronic pain representing a major health concern and with few non-opioid treatment options...